APA (7th ed.) Citation

FS, F. (2022). Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine. Frontiers in oncology, 12, 1029491. https://doi.org/10.3389/fonc.2022.1029491

Chicago Style (17th ed.) Citation

FS, Fan. "Coffee Reduces the Risk of Hepatocellular Carcinoma Probably Through Inhibition of NLRP3 Inflammasome Activation by Caffeine." Frontiers in Oncology 12 (2022): 1029491. https://doi.org/10.3389/fonc.2022.1029491.

MLA (9th ed.) Citation

FS, Fan. "Coffee Reduces the Risk of Hepatocellular Carcinoma Probably Through Inhibition of NLRP3 Inflammasome Activation by Caffeine." Frontiers in Oncology, vol. 12, 2022, p. 1029491, https://doi.org/10.3389/fonc.2022.1029491.